Healthcare provider profile · identity verified

Robert Alan Hoerr, M.D.

Internal Medicine · DULUTH, MN · NPI 1386625192

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	400	109
Atorvastatin Calcium	Atorvastatin Calcium	342	92
Omeprazole	Omeprazole	281	74
Amlodipine Besylate	Amlodipine Besylate	278	76
Gabapentin	Gabapentin	272	60
Losartan Potassium	Losartan Potassium	262	76
Levothyroxine Sodium	Levothyroxine Sodium	227	55
Hydrochlorothiazide	Hydrochlorothiazide	196	55
Metformin Hcl Er	Metformin Hcl	178	50
Duloxetine Hcl	Duloxetine Hcl	165	32
Zolpidem Tartrate	Zolpidem Tartrate	161	31
Lisinopril	Lisinopril	146	38
Furosemide	Furosemide	140	42
Metoprolol Succinate	Metoprolol Succinate	138	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	31
Pantoprazole Sodium	Pantoprazole Sodium	126	28
Metformin Hcl	Metformin Hcl	125	34
Tamsulosin Hcl	Tamsulosin Hcl	123	31
Tramadol Hcl	Tramadol Hcl	113	27
Sertraline Hcl	Sertraline Hcl	107	32
Pregabalin	Pregabalin	89	20
Metoprolol Tartrate	Metoprolol Tartrate	88	23
Warfarin Sodium	Warfarin Sodium	88	24
Bupropion Xl	Bupropion Hcl	87	22
Xarelto	Rivaroxaban	87	19
Potassium Chloride	Potassium Chloride	83	21
Telmisartan	Telmisartan	82	29
Ezetimibe	Ezetimibe	81	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	78	24
Albuterol Sulfate Hfa	Albuterol Sulfate	77	37
Jardiance	Empagliflozin	72	18
Ozempic	Semaglutide	70	18
Lorazepam	Lorazepam	65	20
Doxepin Hcl	Doxepin Hcl	62	14
Simvastatin	Simvastatin	60	18
Fluticasone Propionate	Fluticasone Propionate	57	21
Clopidogrel	Clopidogrel Bisulfate	56	15
Trazodone Hcl	Trazodone Hcl	56	15
Trulicity	Dulaglutide	56	suppressed
Eliquis	Apixaban	52	12
Famotidine	Famotidine	50	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	11
Escitalopram Oxalate	Escitalopram Oxalate	44	12
Allopurinol	Allopurinol	43	11
Levetiracetam	Levetiracetam	42	suppressed
Oxycodone Hcl	Oxycodone Hcl	42	15
Pravastatin Sodium	Pravastatin Sodium	40	13
Prednisone	Prednisone	40	18
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Baclofen	Baclofen	36	suppressed
Carvedilol	Carvedilol	36	11
Triamcinolone Acetonide	Triamcinolone Acetonide	36	22
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Glimepiride	Glimepiride	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Spironolactone	Spironolactone	35	13
Clonazepam	Clonazepam	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Atenolol	Atenolol	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Azelastine Hcl	Azelastine Hcl	30	15
Doxycycline Hyclate	Doxycycline Hyclate	29	15
Hydromorphone Hcl	Hydromorphone Hcl	29	suppressed
Celecoxib	Celecoxib	28	suppressed
Finasteride	Finasteride	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Torsemide	Torsemide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Diazepam	Diazepam	26	suppressed
Linzess	Linaclotide	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	25	14
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Azithromycin	Azithromycin	23	16
Mirtazapine	Mirtazapine	21	suppressed
Nystatin	Nystatin	21	suppressed
Valsartan	Valsartan	21	suppressed
Digoxin	Digoxin	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Estradiol	Estradiol	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Ketoconazole	Ketoconazole	14	11
Mounjaro	Tirzepatide	14	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Ondansetron Odt	Ondansetron	14	suppressed
Primidone	Primidone	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Dapsone	Dapsone	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Ramipril	Ramipril	13	suppressed
Risperidone	Risperidone	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Modafinil	Modafinil	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clonidine	Clonidine	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error